Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.54 |
| ▸ | SCN4A known ✓ | P35499 | 6/20 | 0.48 |
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6852974 | 1.00 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL7185884 | 1.00 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL5945406 | 1.00 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL29503095 | 0.97 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL43945 | 0.97 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL170928 | 0.97 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL176808 | 0.97 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| Benzene SCHEMBL28170835 | 0.97 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| Iodide SCHEMBL6672339 | 0.95 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL28382272 | 0.95 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118524712-A | Voltage stabilizing diode and preparation method and application thereof | 澳门大学 | 2024-08-20 | — | — | CN | claimed |
| US-20240216298-A1 | TOPICAL TREATMENT OF HERPES INFECTIONS | TECH SWERVE, LLC | 2024-07-04 | — | — | US | claimed |
| CN-117769588-A | Methods and reagents for enhancing chemiluminescent signals | 欧蒙医学实验诊断股份公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117696259-A | Method for simultaneously and efficiently removing impurities and whitening phosphogypsum | 中南民族大学 | 2024-03-15 | — | — | CN | claimed |
| EP-4294903-A1 | EFFERVESCENT GERMICIDAL COMPOSITIONS | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2023-12-27 | — | — | EP | claimed |
| WO-2023200764-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | BLUEWILLOW BIOLOGICS, INC. (US) | 2023-10-19 | — | — | WO | claimed |
| CN-116888249-A | Effervescent bactericidal composition | 雷克特和科尔曼(海外)家用卫生有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-20230257682-A1 | FABRIC CARE COMPOSITIONS WITH DOSE-DEPENDENT ANTIMICROBIAL ACTIVITIES THAT REDUCE THE RISK OF INFECTION AND PROMOTE HEALTH AND HYGIENE WHEN USED DISCRETELY OR SYNERGISTICALLY IN A MACHINE WASHING AND DRYING LAUNDRY PROGRAM | TJBS IP Management, LLC (US) | 2023-08-17 | — | — | US | claimed |
| EP-4121220-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2023-01-25 | — | — | EP | claimed |
| CN-115135307-A | Carrier for cell delivery | 株式会社ITO | 2022-09-30 | — | — | CN | claimed |
| CN-1417249-A | Composite polyolefin/sio2 nano particle and its prepn | UNIV TSINGHUA (CN) | 2003-05-14 | — | — | CN | claimed |
| US-20030053929-A1 | System and method of treating a porous material of a vehicle | ZIEBART INTERNATIONAL CORPORATION | 2003-03-20 | — | — | US | claimed |
| CN-1258448-A | Hand disinfectant for preoperation use and personal hygiene and its preparation | TIANJIN AIHUA FRESHENER CO LTD (CN) | 2000-07-05 | — | — | CN | claimed |
| EP-0918458-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1998011778-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-03-26 | — | — | WO | claimed |
| EP-0623166-B1 | LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL | PROCTER & GAMBLE (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0623166-A1 | LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL. | PROCTER & GAMBLE (US) | 1994-11-09 | — | — | EP | claimed |
| EP-0610302-A1 | METHOD OF ANALYSIS | CTS BIOCIDES LTD. (GB) | 1994-08-17 | — | — | EP | claimed |
| WO-1993015173-A1 | LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL | THE PROCTER & GAMBLE COMPANY (US) | 1993-08-05 | — | — | WO | claimed |
| WO-1993009430-A1 | METHOD OF ANALYSIS | CTS BIOCIDES LTD. (GB) | 1993-05-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030053929-A1 | System and method of treating a porous material of a vehicle | SPOUT1, CLPP, SORD | SLC6A4 1422/4885SCN4A 4097/4885DPP4 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.